Xi Zheng-Xiong, Stein Elliot A
Department of Cell Biology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Psychopharmacology (Berl). 2002 Nov;164(2):144-50. doi: 10.1007/s00213-002-1190-3. Epub 2002 Sep 5.
While the role of the mesocorticolimbic (MCL) dopamine (DA) system in mediating the reinforcing properties of drugs of abuse has been well established, how and where other neurotransmitter systems interact to modify this system is less well understood.
The present study sought to assess whether blockade of ionotropic glutamate receptors in the ventral tegmental area (VTA) would modulate heroin self-administration (SA) behavior in rats.
The effects of systemic or regional administration of ionotropic glutamate receptor antagonists into the VTA on the maintenance of heroin SA were assessed. Rats were reinforced each time they responded on a lever with a single injection of intravenous heroin. To determine the specificity of their effects on heroin SA, the ability of these antagonists to modify locomotion and food-reinforced behavior was also examined.
Systemic or regional administration of the non-competitive NMDA antagonist dizocilpine into the VTA significantly increased the rate of heroin SA and shifted the heroin dose-response curve to the right. Similarly, when systemically administered, ketamine, another non-competitive NMDA antagonist, also increased the rate of heroin SA. However, when administered directly into the VTA, ketamine or AP5 [ D-(-)-2-amino-5-phosphonopentanoic acid, a competitive NMDA antagonist], dose-dependently blocked heroin SA. In contrast, 6,7-dinitroquinoxaline-2,3-dione (DNQX), an AMPA/kainate receptor antagonist, significantly increased heroin SA.
These data suggest that ionotropic glutamate receptors in the VTA, presumably by modulating MCL DA efferents and/or tegmental interneurons, modulate opiate reinforcement.
虽然中脑皮质边缘(MCL)多巴胺(DA)系统在介导滥用药物的强化特性方面的作用已得到充分证实,但其他神经递质系统如何以及在何处相互作用以改变该系统却鲜为人知。
本研究旨在评估腹侧被盖区(VTA)中离子型谷氨酸受体的阻断是否会调节大鼠的海洛因自我给药(SA)行为。
评估了向VTA全身或局部给予离子型谷氨酸受体拮抗剂对海洛因SA维持的影响。每次大鼠按压杠杆时,给予单次静脉注射海洛因进行强化。为了确定它们对海洛因SA作用的特异性,还检测了这些拮抗剂改变运动和食物强化行为的能力。
向VTA全身或局部给予非竞争性NMDA拮抗剂地佐环平显著增加了海洛因SA的速率,并使海洛因剂量反应曲线右移。同样,另一种非竞争性NMDA拮抗剂氯胺酮全身给药时也增加了海洛因SA的速率。然而,直接注入VTA时,氯胺酮或AP5 [D -(-)-2-氨基-5-磷酸戊酸,一种竞争性NMDA拮抗剂]剂量依赖性地阻断海洛因SA。相比之下,AMPA/海人藻酸受体拮抗剂6,7-二硝基喹喔啉-2,3-二酮(DNQX)显著增加了海洛因SA。
这些数据表明,VTA中的离子型谷氨酸受体可能通过调节MCL DA传出纤维和/或被盖中间神经元来调节阿片类药物的强化作用。